Literature DB >> 17875635

Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.

Jason D Price1, Kim R Simpfendorfer, Radhakrishnam R Mantena, James Holden, William R Heath, Nico van Rooijen, Richard A Strugnell, Odilia L C Wijburg.   

Abstract

Interleukin-12 (IL-12) and IL-18 are both central to the induction of gamma interferon (IFN-gamma), and various roles for IL-12 and IL-18 in control of intracellular microbial infections have been demonstrated. We used IL-12p40(-/-) and IL-18(-/-) mice to further investigate the role of IL-12 and IL-18 in control of Salmonella enterica serovar Typhimurium. While C57BL/6 and IL-18(-/-) mice were able to resolve attenuated S. enterica serovar Typhimurium infections, the IL-12p40(-/-) mice succumbed to a high bacterial burden after 60 days. Using ovalbumin (OVA)-specific T-cell receptor transgenic T cells (OT-II cells), we demonstrated that following oral infection with recombinant S. enterica serovar Typhimurium expressing OVA, the OT-II cells proliferated in the mesenteric lymph nodes of C57BL/6 and IL-18(-/-) mice but not in IL-12p40(-/-) mice. In addition, we demonstrated by flow cytometry that equivalent or increased numbers of T cells produced IFN-gamma in IL-12p40(-/-) mice compared with the numbers of T cells that produced IFN-gamma in C57BL/6 and IL-18(-/-) mice. Finally, we demonstrated that removal of macrophages from S. enterica serovar Typhimurium-infected C57BL/6 and IL-12p40(-/-) mice did not affect the bacterial load, suggesting that impaired control of S. enterica serovar Typhimurium infection in the absence of IL-12p40 is not due to reduced macrophage bactericidal activities, while IL-18(-/-) mice did rely on the presence of macrophages for control of the infection. Our results suggest that IL-12p40, but not IL-18, is critical to resolution of infections with attenuated S. enterica serovar Typhimurium and that especially the effects of IL-12p40 on proliferative responses of CD4+ T cells, but not the ability of these cells to produce IFN-gamma, are important in the resolution of infection by this intracellular bacterial pathogen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875635      PMCID: PMC2168367          DOI: 10.1128/IAI.00971-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Authors:  V K Kuchroo; M P Das; J A Brown; A M Ranger; S S Zamvil; R A Sobel; H L Weiner; N Nabavi; L H Glimcher
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

2.  Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection.

Authors:  Bärbel Raupach; Soo-Kyung Peuschel; Denise M Monack; Arturo Zychlinsky
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major.

Authors:  Z E Wang; S Zheng; D B Corry; D K Dalton; R A Seder; S L Reiner; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells.

Authors:  T Germann; M K Gately; D S Schoenhaut; M Lohoff; F Mattner; S Fischer; S C Jin; E Schmitt; E Rüde
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

5.  Role of gamma interferon in late stages of murine salmonellosis.

Authors:  A Muotiala; P H Mäkelä
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.

Authors:  B M Saunders; Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 7.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.

Authors:  N Van Rooijen; A Sanders
Journal:  J Immunol Methods       Date:  1994-09-14       Impact factor: 2.303

8.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

9.  Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Microb Pathog       Date:  1992-12       Impact factor: 3.738

View more
  7 in total

1.  Protective efficacy of a Salmonella Typhimurium ghost vaccine candidate constructed with a recombinant lysozyme-PMAP36 fusion protein in a murine model.

Authors:  Ja Young Moon; So Young Kim; Won Kyong Kim; Zhili Rao; Jung Hee Park; Ji Young Mun; Boram Kim; Hyo Sun Choi; Jin Hur
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

Review 2.  IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Authors:  Michele W L Teng; Edward P Bowman; Joshua J McElwee; Mark J Smyth; Jean-Laurent Casanova; Andrea M Cooper; Daniel J Cua
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

3.  Cholinergic stimulation of the immune system protects against lethal infection by Salmonella enterica serovar Typhimurium.

Authors:  Maria J Fernandez-Cabezudo; Dietrich E Lorke; Sheikh Azimullah; Milena Mechkarska; Mohammed Y Hasan; Georg A Petroianu; Basel K al-Ramadi
Journal:  Immunology       Date:  2010-04-08       Impact factor: 7.397

4.  Protective efficacy of the recombinant lysozyme-PMAP36 fusion protein-inactivated Salmonella Typhimurium vaccine candidate via oral immunization in a murine model.

Authors:  Jayoung Moon; Soyoung Kim; Wonkyong Kim; Zhili Rao; Junghee Park; Byungyong Park; Jin Hur
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

5.  Inhibition of ROS and upregulation of inflammatory cytokines by FoxO3a promotes survival against Salmonella typhimurium.

Authors:  Julie Joseph; Emmanuelle S Ametepe; Naveen Haribabu; Gerard Agbayani; Lakshmi Krishnan; Alexandre Blais; Subash Sad
Journal:  Nat Commun       Date:  2016-09-07       Impact factor: 14.919

6.  Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid.

Authors:  Clare L Kinnear; Richard A Strugnell
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

7.  Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge.

Authors:  Qiong Liu; Qing Liu; Jie Yi; Kang Liang; Bo Hu; Xiangmin Zhang; Roy Curtiss; Qingke Kong
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.